Worry as a window into the lives of people who use injection drugs: A factor analysis approach

Harm Reduction Journal

Volumn 6, Issue , 2009, Pages

  Exner, Heidi ^a   Gibson, Erin K ^a   Stone, Ryan ^b   Lindquist, Jennifer ^b   Cowen, Laura ^b   Roth, Eric A ^b  

^a AIDS Vancouver Island   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DRUG OVERDOSE; FACTORIAL ANALYSIS; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

EID: 68949208647     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-6-20     Document Type: Article

References (22)

1. Institute of Medicine Preventing HIV Infection among Injecting Drug Users in High-Risk Countries: An Assessment of the Evidence Washington: National Academies Press 2007.
2. Aceijas C Rhodes T Global estimates of prevalence of HCV infection among injecting drug users Inter J Drug Policy 2006, 18(5):352-358. 10.1016/ j.drugpo.2007.04.004
3. Canadian HIV/AIDS Legal Network "Nothing about us without us". Greater, meaningful involvement of people who use illegal drugs: A public health, ethical and human rights imperative 2006 http://www.aidslaw.ca/publications/publicationsdocEN.php?ref=85
4. Des Jarlais D Friedman S Hopkins W Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users Ann Internal Med 1985, 103:775-759.
5. Hagan H Theile H Weiss N Hopkins S Duchin J Alexander E Sharing of drug preparation equipment as a risk factor for Hepatitis C Amer J Public Health 2001, 91:42-46. 10.2105/AJPH.91.9.1350
6. Friedman S Curtis R Neaigus A Jose B Des Jarlais D Social Networks, Drug Injectors' Lives, and HIV/AIDS New York, Kluwer Academic 1999.
7. Neaigus A Freidman S Kottiri B Des Jarlais D HIV risk networks and HIV transmission among injecting drug users Evaluation and Program Planning 2001, 24:221-226. 10.1016/S0149-7189(01)00012-X
8. Rhodes T Simpson G Crofts N Ball A Dehne K Khodakevich I Drug injecting, rapid HIV spread, and the "risk environment": Implications for assessment and response AIDS 1999, 13(Supp A):S259-269. 10885783
9. Rhodes T Singer M Bourgois P Friedman S Strathdee S The structural production of HIV risk among injecting drug users Soc Sci Med 2005, 61:1026-1044. 10.1016/j.socscimed.2004.12.024 15955404
10. Smith K Why are they worried? Concerns about HIV/AIDS in rural Malawi Demographic Research, Special Collection 2003, 1:277-317.
11. Smith K Watkins SC Perceptions of risk and strategies for prevention: Responses to HIV/AIDS in rural Malawi Soc Sci Med 2005, 60:649-660. 10.1016/j.socscimed.2004.06.009 15550312
12. Busza J How does a "risk group" perceive risk? Voices of Vietname se sex workers in Cambodia Journal of Psychology and Human Sexuality 2005, 17(1-2):65-82.
13. Mizuno Y Percell D Borowski T Knight K the SUDIS Team The life priorities of HIV-seropositive injection drug users: Findings from a community-based sample AIDS and Behavior 2003, 7(4):395-403. 10.1023/ B:AIBE.0000004731.94734.77 14707536
14. Brogly S Mercier C Brunea C Palepu A Franco E Towards more effective public health programming for injection drug users: Development and evaluation of the Injection Drug User Quality of Life Scale Subst Use and Misuse 2003, 38(7):965-992. 10.1081/JA-120017619
15. Bourgois P The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk and everyday violence in San Francisco shooting encampments Subst Use and Misuse 1999, 33:2323-2351. 10.3109/ 10826089809056260
16. Bouhnik A Chesney M Carrieri P Gallais H Morneau J Moatti J-P Obadia Y Spire B the MANIF 2000 Study Group Nonadherence among HIV-infected injection drug users: The impact of social instability J Acquired Immun Syndr 2002, 31(Supp 3):S149-S153.
17. Wood E Kerr T Tyndall M Montaner J A review of barriers and facilitators of HIV treatment among injection drug users AIDS 2008, 22:1247-1256. 10.1097/QAD.0b013e3282fbd1ed 18580603
18. Wood E Tyndall M Spittal P Li K Hogg R Montaner J O'Shaughnessey M Schechter M Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme AIDS 2002, 16(6):941-943. 10.1097/00002030-200204120-00021 11919503
19. Hatcher L A Step-by-Step Approach to Using SAS for Factor Analysis and Structural Equation Modeling Cary, NC: SAS Press 1994.
20. Costello A Osborne J Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis Practical Assessment, Research Evaluation 2005, 10(7):1-9.
21. Loehlin J Latent Variable Models: An Introduction to Factor, Path, and Structural Analyses Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers 1987.
22. Strathdee S Patrick D Currie S Cornelisse P Rekart M Montaner J Schechter M O'Shaughnessy M Needle exchange is not enough: Lessons from the Vancouver injection drug use study AIDS 1997, 11:F59-65. 10.1097/ 00002030-199708000-00001 9223727